CryoPort (NASDAQ:CYRX) Insider Sells $16,112.00 in Stock

CryoPort, Inc. (NASDAQ:CYRX) insider Edward Zecchini sold 2,014 shares of CryoPort stock in a transaction on Monday, March 16th. The stock was sold at an average price of $8.00, for a total value of $16,112.00. Following the completion of the sale, the insider directly owned 109,719 shares of the company’s stock, valued at approximately $877,752. The trade was a 1.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

CryoPort Stock Performance

Shares of CYRX stock traded up $0.36 during mid-day trading on Tuesday, hitting $8.36. The company’s stock had a trading volume of 401,705 shares, compared to its average volume of 429,763. The stock has a market cap of $416.83 million, a price-to-earnings ratio of 6.33 and a beta of 1.69. CryoPort, Inc. has a 52-week low of $4.63 and a 52-week high of $11.45. The business has a 50-day moving average price of $9.19 and a 200 day moving average price of $9.36.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.02). CryoPort had a net margin of 42.35% and a negative return on equity of 8.22%. The business had revenue of $45.45 million for the quarter, compared to analysts’ expectations of $42.92 million. Equities research analysts predict that CryoPort, Inc. will post -0.99 EPS for the current fiscal year.

Institutional Investors Weigh In On CryoPort

A number of large investors have recently made changes to their positions in the company. Assenagon Asset Management S.A. lifted its stake in shares of CryoPort by 37.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company’s stock worth $14,208,000 after purchasing an additional 408,263 shares during the period. SG Americas Securities LLC boosted its holdings in shares of CryoPort by 663.2% in the third quarter. SG Americas Securities LLC now owns 127,280 shares of the company’s stock worth $1,207,000 after buying an additional 110,602 shares during the last quarter. Bullseye Asset Management LLC grew its position in CryoPort by 23.0% during the second quarter. Bullseye Asset Management LLC now owns 260,168 shares of the company’s stock valued at $1,941,000 after buying an additional 48,605 shares during the period. Thematics Asset Management grew its position in CryoPort by 12.8% during the second quarter. Thematics Asset Management now owns 1,914,885 shares of the company’s stock valued at $14,285,000 after buying an additional 216,937 shares during the period. Finally, Kennedy Capital Management LLC purchased a new stake in CryoPort during the second quarter valued at approximately $4,084,000. 92.90% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on CYRX. Weiss Ratings reissued a “sell (d+)” rating on shares of CryoPort in a report on Monday, December 29th. Wall Street Zen cut shares of CryoPort from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Finally, Needham & Company LLC lifted their target price on shares of CryoPort from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, March 4th. Eight investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $12.94.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.